UnitedHealth Group's Robust Q2 Performance: Oppenheimer's View On Profit Increase And Revised FY23 Guidance

Oppenheimer analyst Michael Wiederhorn reiterated an Outperform rating on UnitedHealth Group UNH, with a price target of $610.

The company reported nearly $5.5 billion in Q2, up 8% Y/Y in profits as its health insurance plans and Optum medical provider businesses grew by "double-digit" percentages despite rising costs

Wiederhorn notes that the company's Optum business complements its core managed care operations and continues to account for a large share of earnings. However, the analyst adds that Optum Health was a slight underperformer in Q2. 

The analyst adds that UNH is seeing stabilization in utilization relative to the June commentary that pointed to a pickup in MA. Notably, UNH is not seeing any impact to comm'l/Medicaid, suppressing concerns in the marketplace.

Though the Q2 beat ($6.14 vs. OPCO/Street $5.96/$5.99E) was driven by investment income, trends appear stable, and management had enough confidence to raise the bottom-end of its FY2023 guidance range, the analyst notes. 

UnitedHealth revised its FY23 net earnings outlook, to $23.45-$23.75 per share and adjusted net earnings to $24.70-$25.00 per share (vs. consensus of $24.80), compared to prior guidance of $23.25-$23.75 per share and $24.50-$25.00 per share, respectively

The analyst believes that UNH is well positioned under its diversification, strong track record, elite management team, and exposure to certain higher-growth businesses. 

Post-Q2, Wiederhorn tweaked FY2023/2024/2025 EPS estimates to $24.90/$28.04/$31.58 from $24.85/$28.07/$31.94. 

Price Action: UNH shares are trading higher by 0.72% to $483.65 on the last check Monday.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorEquitiesNewsPrice TargetReiterationMarketsAnalyst RatingsTrading IdeasGeneralBriefsExpert Ideas
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!